vimarsana.com

Latest Breaking News On - Michele boldrin - Page 1 : vimarsana.com

Patents, Pharma, Government: The Unholy Alliance – Analysis

Patents, Pharma, Government: The Unholy Alliance – Analysis
eurasiareview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurasiareview.com Daily Mail and Mail on Sunday newspapers.

Cross-party yellow peril

Parliament’s Intelligence and Security Committee has produced a lurid account of the challenge represented by China. Mike Macnair argues that the UK is playing catch-up with the US hegemon

ConJur - Corrêa: A patente incentiva de fato a inovação em medicamentos?

ConJur - Corrêa: A patente incentiva de fato a inovação em medicamentos?
conjur.com.br - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from conjur.com.br Daily Mail and Mail on Sunday newspapers.

Tripped up: All you need to know about the Covid-19 TRIPS waiver and what it may achieve for SA (and what it won t)

Tripped up: All you need to know about the Covid-19 TRIPS waiver and what it may achieve for SA (and what it won’t) Franziska Sucker Franziska Sucker is associate professor at the School of Law, University of the Witwatersrand On 5 May 2021, following enormous pressure, ambassador Katherine Tai announced the US government’s support for waiving intellectual property (IP) protection for Covid-19 vaccines. The following morning, Ursula von der Leyen, the European Commission president, declared the EU ready to discuss the “US proposal” even while some European governments, especially Germany, vehemently opposed the idea.  This happened in response to the October 2020 joint waiver request made by South Africa and India. They proposed a waiver allowing World Trade Organization (WTO) members to suspend their obligations to apply several (

Tripped up: All you need to know about the Covid-19 TRI

Maverick Citizen: Explainer Tripped up: All you need to know about the Covid-19 TRIPS waiver and what it may achieve for SA (and what it won’t) By Franziska Sucker• 11 May 2021 Activists outside Pfizer headquarters in Manhattan, New York demand that US President Joe Biden support the TRIPS waiver, which would lift the intellectual property protection for Covid-19 vaccines. (Photo: Steven Francis Kong) A waiver would not be a global answer to the pandemic but would be a step in the right direction. It would remove the legal barriers that prevent cross-border cooperation in generic manufacturing of Covid-19 medical products as well as cross-border manufacturing capacity building – both long-term considerations. In the short and medium term a waiver would facilitate generic export to members in need (with limited and no manufacturing capacity, eg African countries) and simplify and potentially speed up generic production (for those with manufacturing capacity such as India)

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.